The ERK/MAPK pathway is overexpressed and activated in gallbladder cancer
Autor
Buchegger, Kurt
Silva, Ramón
Lopez, Jaime
Ili, Carmen
Araya, Juan Carlos
Leal, Pamela
Brebi, Priscilla
Riquelme, Ismael
Roa, Juan Carlos
Resumen
Gallbladder cancer (GBC) is a highly fatal disease with poor prognosis and few therapeutic alternatives. Molecular profiling has revealed that the deregulation in the ERK/MAPK signaling pathway plays a crucial role in many disease and malignancies, including GBC. The aim of this study was to measure the expression of ERK1/2 and p-ERK1/2 in a population with high GBC-related mortality, such as the Chilean population, and characterize the protein expression of this ERK/MAPK pathway in seven GBC cell lines. Immunohistochemistry (IHC) for ERK1/2 and p-ERK1/2 was performed in 123 GBC tissues and 37 chronic cholecystitis (CC) tissues. In addition, protein expression analysis by western blot for ERK1/2, p-ERK1/2, EGFR, ERBB2 and ERBB3 were performed in seven GBC cell lines (GB-d1, G415, NOZ, OCUG-1, TGBC-1, TGBC-2 and TGBC-24). A higher ERK1/2 and p-ERK1/2 expression was found in GBC tissues compared to chronic cholecystitis (CC) tissues (P < 0.001). However, neither significant differences in overall survival nor significant associations with any of the clinicopathological features were found by comparing low and high expression of both ERK1/2 and p-ERK1/2. Western blot analysis of seven GBC cell lines showed that, in general, GB-d1, G415 and NOZ cells evidenced a strong expression of ERK1/2, p-ERK1/2, EGFR, ERBB2 and ERBB3. Therefore, ERK1/2 and p-ERK1/2 seem to be important in the development of GBC and GB-d1, G415 and NOZ cell lines may be used as experimental models for further in vitro and in vivo studies that help to decipher the role of MAPK/ERK pathway in gallbladder carcinogenesis.
Colecciones
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Article
Landscape of genome-wide dna methylation of colorectal cancer metastasis (2020)
Ili, Carmen; Buchegger, Kurt; Demond, Hannah; Castillo-Fernandez, Juan; Kelsey, Gavin D.; Zanella, Louise; Abanto, Michel; Riquelme, Ismael; López, Jaime; Viscarra, Tamara; ... (MDPI AG, 2020-09-22)Colorectal cancer is a heterogeneous disease caused by both genetic and epigenetics factors. Analysing DNA methylation changes occurring during colorectal cancer progression and metastasis formation is crucial for the ... -
Article
Long Non-Coding RNAs (lncRNAs) as Regulators of the PI3K/AKT/mTOR Pathway in Gastric Carcinoma (2024)
Riquelme, Ismael; Pérez-Moreno, Pablo; Mora-Lagos, Bárbara; Ili, Carmen; Brebi, Priscilla; Roa, Juan Carlos (Multidisciplinary Digital Publishing Institute (MDPI), 2023)Gastric cancer (GC) represents ~10% of the global cancer-related deaths, increasingly affecting the younger population in active stages of life. The high mortality of GC is due to late diagnosis, the presence of metastasis ... -
Article
Epigallocatechin gallate enhances MAL-PDT cytotoxic effect on PDT-resistant skin cancer squamous cells (2022)
León, Daniela; Buchegger, Kurt; Silva, Ramón; Riquelme, Ismael; Viscarra, Tamara; Mora-Lagos, Bárbara; Zanella, Louise; Schafer, Fabiola; Kurachi, Cristina; Roa, Juan Carlos; ... (International journal of molecular sciences, 2020-01)Photodynamic therapy (PDT) has been used to treat certain types of non-melanoma skin cancer with promising results. However, some skin lesions have not fully responded to this treatment, suggesting a potential PDT-resistant ...